Skip to content
sellWeak

University Of Texas/texas Am Investment Management Co sold $139k of RNTX

owner at Aileron Therapeutics, Inc.. 31,151 shares at an average of $4.47, traded Apr 29, 2024, filed May 1, 2024.

Warning score
23
Value
$139k
31,151 shares
Holdings after
1,779,306
-2% from before
From 52-week low
+328%
low $1.15, close $4.92
From 52-week high
-29%
high $6.93, as of Apr 29, 2024

Score components

  • Role
    10% owner
    +12
  • Trade size
    $139k at market
    +11
  • Share of holdings sold
    Sold 1.7% of holdings
    0
  • Cluster
    No other insider selling within 14 days
    0

What happened after comparable sells

Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.

This signal so far: 1m -23.1%, 3m -47.1%, 6m -7.5%.

Price around the trade, and since

From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.

RNTXOct 13, 2026 · close 0.75
Since filing May 1, 2024: -81.9%SPY +60.1% · excess -141.9%

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™

Rows in this filing

Every transaction in Form 4 0001019231-24-000022, as filed. Open on EDGAR

DateTransactionSharesPriceValueHoldings afterFiled
Apr 29, 2024SOpen-market sale
Common Stock
-6,680$4.92$33k1,803,777May 1, 2024
Apr 29, 2024SOpen-market sale
Common Stock
-274$4.93$1,3511,803,503May 1, 2024
Apr 29, 2024SOpen-market sale
Common Stock
-100$4.94$4941,803,403May 1, 2024
Apr 29, 2024SOpen-market sale
Common Stock
-3,231$5.00$16k1,800,172May 1, 2024
Apr 29, 2024SOpen-market sale
Common Stock
-13$5.01$651,800,159May 1, 2024
Apr 29, 2024SOpen-market sale
Common Stock
-448$5.03$2,2511,799,711May 1, 2024
Apr 30, 2024SOpen-market sale
Common Stock
-45$4.95$2231,799,666May 1, 2024
Apr 30, 2024SOpen-market sale
Common Stock
-45$5.00$2251,799,621May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-3,100$4.10$13k1,796,521May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-100$4.11$4111,796,421May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-1,750$4.12$7,2101,794,671May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-380$4.13$1,5691,794,291May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-1,600$4.15$6,6321,792,691May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-670$4.15$2,7811,792,021May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-400$4.18$1,6721,791,621May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-7,923$4.25$34k1,783,698May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-310$4.26$1,3211,783,388May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-317$4.27$1,3521,783,071May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-100$4.27$4271,782,971May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-200$4.28$8551,782,771May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-337$4.28$1,4421,782,434May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-200$4.29$8571,782,234May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-2,903$4.29$12k1,779,331May 1, 2024
May 1, 2024SOpen-market sale
Common Stock
-25$4.32$1081,779,306May 1, 2024

Related signals

Other insiders at Aileron Therapeutics, Inc. and this insider’s other filings.

ScoreCompanyInsiderValueHoldingsFiled
50Moderate
RNTXbuy
Aileron Therapeutics, Inc.
Josef H Von Rickenbach
director
$50k
47,060 shares
+305%
38Weak
RNTXbuy
Aileron Therapeutics, Inc.
James Brian Windsor
See Remarks
$25k
25,000 shares
+1222%
26Weak
RNTXbuy
Aileron Therapeutics, Inc.
Voss Capital, LLC
owner
$128k
104,183 shares
+13%
29Weak
RNTXbuy
Aileron Therapeutics, Inc.
Voss Capital, LLC
owner
$423k
306,050 shares
+44%
33Weak
RNTXbuy
Aileron Therapeutics, Inc.
James Brian Windsor
President and CEO
$898
400 shares
-
12Weak
RNTXsell
Aileron Therapeutics, Inc.
University Of Texas/texas Am Investment Management Co
owner
$22k
6,607 shares
-0%
21Weak
RNTXsell
Aileron Therapeutics, Inc.
University Of Texas/texas Am Investment Management Co
owner
$81k
24,671 shares
-1%
18Weak
RNTXsell
Aileron Therapeutics, Inc.
University Of Texas/texas Am Investment Management Co
owner
$41k
12,315 shares
-1%
21Weak
RNTXsell
Aileron Therapeutics, Inc.
University Of Texas/texas Am Investment Management Co
owner
$85k
20,315 shares
-1%
37Weak
RNTXbuy
Aileron Therapeutics, Inc.
James Brian Windsor
President and COO
$758
225 shares
-

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

University Of Texas/texas Am Investment Management Co sold $139k of RNTX | InsiderTell